Microanalysis for MDR1 ATPase by high-performance liquid chromatography with a titanium dioxide column

Analytical Biochemistry

Volumn 326, Issue 2, 2004, Pages 262-266

  Kimura, Yasuhisa ^a   Shibasaki, Seiji ^a,b   Morisato, Kei ^c   Ishizuka, Norio ^c   Minakuchi, Hiroyoshi ^c   Nakanishi, Kazuki ^a   Matsuo, Michinori ^a   Amachi, Teruo ^a   Ueda, Mitsuyoshi ^a   Ueda, Kazumitsu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KOBE CITY COLLEGE OF TECHNOLOGY   (Japan)

^c Kyoto Monotech   (Japan)

Author keywords

ATPase; MDR1; Titanium dioxide column

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDES; PURIFICATION; TITANIUM DIOXIDE;

ASSAY SYSTEM; ATP-ASE ACTIVITY; ATPASE; ATPASE REACTION; INORGANIC PHOSPHATES; MDR1; MULTIDRUG RESISTANCE; TRIPHOSPHATE;

COLUMN CHROMATOGRAPHY;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; MULTIDRUG RESISTANCE PROTEIN 1; TITANIUM DIOXIDE;

ARTICLE; COLORIMETRY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 10744227683     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.12.012     Document Type: Article

References (23)

1. Juliano R.L., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 455:1976;152-162.
2. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA. 84:1987;3004-3008.
3. Westphal K., Weinbrenner A., Zschiesche M., Franke G., Knoke M., Oertel R., Fritz P., von Richter O., Warzok R., Hachenberg T., Kauffmann H.M., Schrenk D., Terhaag B., Kroemer H.K., Siegmund W. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin. Pharmacol. Ther. 68:2000;345-355.
4. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:1999;361-398.
5. Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.P., von Richter O., Zundler J., Kroemer H.K. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104:1999;147-153.
6. Suzuki H., Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12:2000;3-12.
7. Chifflet S., Torriglia A., Chiesa R., Tolosa S. A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases. Anal. Biochem. 168:1988;1-4.
8. Samizo K., Ishikawa R., Nakamura A., Kohama K. A highly sensitive method for measurement of myosin ATPase activity by reversed-phase high-performance liquid chromatography. Anal. Biochem. 293:2001;212-215.
9. Sudo J., Terui J., Iwase H., Kakuno K. Assay of ATPase and Na,K-ATPase activity using high-performance liquid chromatographic determination of ADP derived from ATP. J. Chromatogr. B. Biomed. Sci. Appl. 744:2000;19-23.
10. Ushimaru M., Fukushima Y. Complete separation of adenine nucleotides for ATPase activity assay by ion-pair reversed-phase high-performance liquid chromatography. Anal. Biochem. 313:2003;173-175.
11. Matsuda H., Nakamura H., Nakajima T. New ceramic titania: selective adsorbent for organic phosphates. Anal. Sci. 6:1990;911-912.
12. Kioka N., Tsubota J., Kakehi Y., Komano T., Gottesman M.M., Pastan I., Ueda K. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun. 162:1989;224-231.
13. Lerner-Marmarosh N., Gimi K., Urbatsch I.L., Gros P., Senior A.E. Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins. J. Biol. Chem. 274:1999;34711-34718.
14. Mao Q., Scarborough G.A. Purification of functional human P-glycoprotein expressed in Saccharomyces cerevisiae. Biochim. Biophys. Acta. 5:1997;107-118.
15. Loo T.W., Clarke D.M. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. J. Biol. Chem. 270:1995;21449-21452.
16. Sharom F.J., Yu X., Doige C.A. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268:1993;24197-24202.
17. Ambudkar S.V. Purification and reconstitution of functional human P-glycoprotein. J. Bioenerg. Biomembr. 27:1995;23-29.
18. Urbatsch I.L., al-Shawi M.K., Senior A.E. Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. Biochemistry. 33:1994;7069-7076.
19. Rothnie A., Theron D., Soceneantu L., Martin C., Traikia M., Berridge G., Higgins C.F., Devaux P.F., Callaghan R. The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence. Eur. Biophys. J. 30:2001;430-442.
20. Sarkadi B., Price E.M., Boucher R.C., Germann U.A., Scarborough G.A. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267:1992;4854-4858.
21. Scarborough G.A. Drug-stimulated ATPase activity of the human P-glycoprotein. J. Bioenerg. Biomembr. 27:1995;37-41.
22. Mochida Y., Taguchi K., Taniguchi S., Tsuneyoshi M., Kuwano H., Tsuzuki T., Kuwano M., Wada M. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis. 24:2003;1219-1224.
23. Yamada T., Mori Y., Hayashi R., Takada M., Ino Y., Naishiro Y., Kondo T., Hirohashi S. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res. 63:2003;895-901.